Renerve
- Short interest
- 0.00%
- as of 6 May 2025
- Reported shorts
- 1.4K
- Shares on issue
- 109.448M
Renerve (RNV) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $510.4Kvs $271.7K (FY25)
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- −$5.6Mvs −$3.7M (FY25)
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- −$0.035T (source: Derived: trailing 12 months at year end)vs −$0.030 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- +87.8%FY
- EPS YoY
- n/aTTM
- Derived: trailing 12 months at year end
Summary of ReNerve - 2026 Annual Report, 28 Aug 2026
ReNerve reported record quarterly sales of ~$211k for the June 2026 quarter, with annual sales growth of 88% versus the prior corresponding period. No dividend was declared. The company is focused on accelerating sales growth, expanding into newly approved Asia-Pacific markets, and advancing its product pipeline.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 14 Oct 2026
- Gross margin
- 53.2%
- Operating margin
- −1,276.8%
- Net margin
- −1,091.9%
- FCF margin
- −1,165.3%
- ROE
- −133.1%
- ROA
- −103.9%
- FCF conversion
- n/a
- Net cash (excl. leases)
- $1.4M
- Net debt / EBITDA
- n/a
- Current ratio
- 3.1×
- Interest cover
- −586.6×
- Cash dividends paid / net profit
- n/a
- Market cap
- $13.8M
- P/E
- n/a
- P/B
- 4.3×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $510.4K | $271.7K | $177.4K | $128.5K |
| Gross profit | $271.3K | $244.7K | $176.8K | $128.5K |
| Operating income | −$6.5M | −$4.5M | −$3.1M | −$2.2M |
| EBITDA | −$5.5M | −$3.4M | −$2.5M | −$1.7M |
| EBIT | −$5.6M | −$3.5M | −$2.7M | −$1.8M |
| Interest expense | $11.1K | $249.5K | $290.2K | $7.0K |
| Pretax income | −$5.6M | −$3.7M | −$3.0M | −$1.8M |
| Tax | $0 | $0 | $0 | $0 |
| NPAT | −$5.6M | −$3.7M | −$3.0M | −$1.8M |
| Net interest income | $78.8K | −$105.2K | −$290.2K | −$7.0K |
| EPS basic | −$0.035T (source: Derived: trailing 12 months at year end) | −$0.030 | −$0.021 | −$0.013 |
| EPS diluted | −$0.035T (source: Derived: trailing 12 months at year end) | −$0.030 | −$0.021 | −$0.013 |
| Shares | 172.3M | 142.5M | 141.8M | 141.8M |
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- ReNerve - Full Year ResultsFull Year Results28 Aug 2026via asx_announcements
- ReNerve - 2026 Annual ReportAnnual Report28 Aug 2026via asx_announcements
- ReNerve - Appendix 4EAnnual Results28 Aug 2026via asx_announcements
- Q4 FY26 Activities Report and Appendix 4CQuarterly Report29 Jul 2026via asx_announcements
- Q3 FY26 Activities Report and Appendix 4CQuarterly Report30 Apr 2026via asx_announcements
- Half Year Investor PresentationHalf Year Results17 Mar 2026via asx_announcements
- Half Year Investor WebinarHalf Year Results10 Mar 2026via asx_announcements
- 1HFY26 Appendix 4D and Half Year ReportHalf Year Results26 Feb 2026via asx_announcements
- Q2 FY26 Activities Report and Appendix 4CQuarterly Report30 Jan 2026via asx_announcements
- Q1 FY26 Activities Report and Appendix 4CQuarterly Report23 Oct 2025via asx_announcements
Showing 10 of 19 reports